Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Lymphoma • General Internal Medicine • Hematology
How do you approach frontline treatment for an elderly patient with adult T-cell leukemia-lymphoma (ATL)?
What factors do you consider in choosing between BV-CHP/BV-CHEP vs DA-EPOCH/CHOEP with or without mogamulizumab?
Answer from: Medical Oncologist at Academic Institution
More information is needed. As you know, there are four clinical variants of ATL that differ in clinical presentation, prognosis and need for treatment. Are you dealing with acute, lymphoma-type, or unfavorable chronic-type ATL? If so, for elderly patients (≥70 years), a CHOP or CHOP-like regimen...
Sign in or Register to read more